Publications by authors named "June Takeda"

Claim this Profile
T
The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short Report.
Tomomi Oka, Takeshi Nakajima, Makoto Iwasaki, June Takeda, Masako Torishima

EJHaem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of multi-hit TP53-mutated myelodysplastic syndromes with erythroid predominance using allogeneic stem cell transplantation and ruxolitinib.
Seigi Oshima, Junya Kanda, June Takeda, Takashi Sakamoto, Chisaki Mizumoto

Ann Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrow.
Minako Mori, Tomomi Sakai, Tomomi Oka, Maki Sakurada, Makoto Iwasaki, June Takeda

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice.
Yoshihito Horisawa, Tadahiko Matsumoto, June Takeda, Yusuke Tashiro, Ryosuke Nomura

Cancer Rep (Hoboken)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic TNFRSF13B Variant in an Adult Japanese Patient with Common Variable Immunodeficiency.
Naokazu Nakamura, Ryo Ikunari, Yasuhiro Tanaka, Hiroko Tsunemine, June Takeda

Intern Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome.
Naokazu Nakamura, Nao Yamamoto, Tadakazu Kondo, Mayumi Matsumoto, Ryo Ikunari, June Takeda

Int J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SETBP1 is dispensable for normal and malignant hematopoiesis.
Atsushi Tanaka, Koutarou Nishimura, Wataru Saika, Ayana Kon, Yui Koike, June Takeda

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Yasuhito Nannya, Magnus Tobiasson, Shinya Sato, Elsa Bernard, Shigeki Ohtake, June Takeda

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, Sophia Korotev, Carmelo Gurnari, June Takeda

Blood· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
June Takeda, Kenichi Yoshida, Masahiro M Nakagawa, Yasuhito Nannya, Akinori Yoda

Blood Cancer Discov· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency.
Hisaya Kato, Yoshiro Maezawa, Dai Nishijima, Eisuke Iwamoto, June Takeda, Yusuke Takeda

Exp Hematol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Molecular pathogenesis and therapeutic targets in acute erythroid leukemia].
June Takeda

Rinsho Ketsueki· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia.
Yotaro Ochi, Kenichi Yoshida, Ying-Jung Huang, Ming-Chung Kuo, Yasuhito Nannya, June Takeda

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Hidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, Yutarou Harata, Moe Higashitani, June Takeda

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel DDX41 variants in Thai patients with myeloid neoplasms.
Chantana Polprasert, June Takeda, Pimjai Niparuck, Thanawat Rattanathammethee, Arunrat Pirunsarn

Int J Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Yosaku Watatani, Yasuharu Sato, Hiroaki Miyoshi, Kana Sakamoto, Kenji Nishida, June Takeda

Leukemia· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and transcriptional landscape of plasma cells in POEMS syndrome.
Yuhei Nagao, Naoya Mimura, June Takeda, Kenichi Yoshida, Yusuke Shiozawa, Yusuke Takeda

Leukemia· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular pathogenesis of disease progression in MLL-rearranged AML.
Shinichi Kotani, Akinori Yoda, Ayana Kon, Keisuke Kataoka, Yotaro Ochi, June Takeda

Leukemia· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent germline mutations of in sporadic subcutaneous panniculitis-like T-cell lymphoma.
Chantana Polprasert, Yasuhide Takeuchi, Nobuyuki Kakiuchi, Kenichi Yoshida, Thamathorn Assanasen, June Takeda

Blood Adv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonally related diffuse large B-cell lymphoma and interdigitating dendritic cell sarcoma sharing translocation.
Yotaro Ochi, Nobuhiro Hiramoto, Tetsuichi Yoshizato, Yuichiro Ono, June Takeda

Haematologica· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent mutations in -rearranged acute myeloid leukemia.
Hidemasa Matsuo, Kenichi Yoshida, Kazutaka Fukumura, Kana Nakatani, Yuki Noguchi, June Takeda

Blood Adv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated molecular analysis of adult T cell leukemia/lymphoma.
Keisuke Kataoka, Yasunobu Nagata, Akira Kitanaka, Yuichi Shiraishi, Teppei Shimamura, June Takeda

Nat Genet· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.
Yasuyuki Arai, Kazunari Aoki, June Takeda, Tadakazu Kondo, Tetsuya Eto

J Hematol Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.
Yasuyuki Arai, June Takeda, Kazunari Aoki, Tadakazu Kondo, Satoshi Takahashi

Blood· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.
Takao Fujisawa, June Takeda, Kazunari Aoki, Takayuki Ishikawa

Ann Hematol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis